Overview

A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The hypothesis is that administration of two courses of antenatal corticosteroids, compared to one course, will show a 40% reduction in the incidence of composite neonatal morbidity in patients delivering prior to 34 weeks' gestation.
Phase:
Phase 4
Details
Lead Sponsor:
Obstetrix Medical Group
Treatments:
BB 1101
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate